GRI Bio, Inc.
GRI
$1.80
-$0.20-10.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 21.91% | 16.37% | -1.34% | 58.81% | -26.23% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -43.11% | -34.35% | 36.34% | 57.98% | 28.36% |
| Operating Income | 43.11% | 34.35% | -36.34% | -57.98% | -28.36% |
| Income Before Tax | 43.19% | 34.41% | -36.50% | -58.22% | -28.53% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 43.19% | 34.41% | -36.50% | -58.22% | -28.53% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 43.19% | 34.41% | -36.50% | -58.22% | -28.53% |
| EBIT | 43.11% | 34.35% | -36.34% | -57.98% | -28.36% |
| EBITDA | 43.09% | 34.36% | -36.35% | -58.01% | -28.37% |
| EPS Basic | 97.52% | 99.01% | 93.98% | -- | -- |
| Normalized Basic EPS | 97.52% | 99.01% | 88.07% | -- | -- |
| EPS Diluted | 97.52% | 99.01% | 93.98% | -- | -- |
| Normalized Diluted EPS | 97.52% | 99.01% | 88.07% | -- | -- |
| Average Basic Shares Outstanding | 2,190.61% | 6,501.06% | 1,046.86% | -- | -- |
| Average Diluted Shares Outstanding | 2,190.61% | 6,501.06% | 1,046.86% | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |